ACCOUNT

Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

PGe
NEWSLETTERS
PG STORE
ARCHIVES

CLASSIFIEDS

OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS

CONTACT US
ADVERTISING
CAREER OPPORTUNITIES

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cortexyme, Inc. - Common Stock (NQ:CRTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 29, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cortexyme, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

The 10 Most Shorted Stocks Right Now for Friday, Dec. 17 ↗

December 17, 2021

Shorted stocks continue to be of interest to retail traders looking for the next big day trade and we're diving into some top candidates!

Via InvestorPlace

5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The Leaderboard ↗

December 06, 2021

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYS...

Via Benzinga

Cortexyme to Present at 4th Annual Evercore ISI HealthCONx Conference on November 30th

November 23, 2021

From Cortexyme, Inc.

Via Business Wire

Could It Finally Be Time To Step Up to The Plate With GME Stock? ↗

November 18, 2021

There's mixed messages being sent to bullish investors other than apes, but the next inning or two of play look promising for GME stock.

Via InvestorPlace

Cassava Pops As Cortexyme Dives — Why One Alzheimer's Stock Is 'Back On Track' ↗

November 11, 2021

An analyst says Cassava is on track, but Cortexyme took another beating Thursday.

Via Investor's Business Daily

Why Are Cortexyme Shares Falling Today? ↗

November 11, 2021

Cortexyme Inc (NASDAQ: CRTX) has presented additional data from its Phase 2/3 GAIN Trial at the Clinical Trials on Alzheimer's Disease Conference. The...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 11, 2021

Gainers Liquidia (NASDAQ:LQDA) stock inc...

Via Benzinga

Cortexyme’s Atuzaginstat Slowed Cognitive Decline in Participants With Alzheimer’s Disease and P. Gingivalis Infection in Phase 2/3 GAIN Trial: Additional Top-line Data Presented at CTAD 2021

November 11, 2021

From Cortexyme, Inc.

Via Business Wire

The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts ↗

November 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Commences Late-Stage Study Of Heart Failure Treatment Merck &...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Cortexyme to Present Additional Top-line GAIN Trial Results and Analysis at CTAD 2021 on November 11th

November 04, 2021

From Cortexyme, Inc.

Via Business Wire

This Is What Whales Are Betting On Cortexyme ↗

November 03, 2021

Someone with a lot of money to spend (and possibly insider knowledge) has taken a bullish stance on Cortexyme (NASDAQ:CRTX). And retail traders should know. We noticed this today...

Via Benzinga

71 Biggest Movers From Yesterday ↗

November 03, 2021

Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Down 76%: Is Cortexyme Stock a Bargain? ↗

October 28, 2021

The biotech's stock took a big hit after its lead product candidate flunked a key clinical trial.

Via The Motley Fool

Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors ↗

October 28, 2021

Another new drug candidate for the treatment of Alzheimer's disease failed miserably in a clinical trial.

Via The Motley Fool

64 Biggest Movers From Yesterday ↗

October 28, 2021

Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...

Via Benzinga

CRTX Stock: What to Know as Cortexyme Plummets 75% ↗

October 27, 2021

Today, investors in CRTX stock lament a rather poor announcement from the company that a key clinical trial missed its primary endpoint.

Via InvestorPlace

Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Cortexyme Shares Plunge ↗

October 27, 2021

Toward the end of trading Wednesday, the Dow traded down 0.23% to 35,674.01 while the NASDAQ rose 0.81% to 15,358.79. The S&P also rose, gaining 0.14% to 4,581.2. The U.S. has...

Via Benzinga

Topics Stocks

Why Cortexyme Shares Are Falling ↗

October 27, 2021

Cortexyme Inc (NASDAQ: CRTX) shares are trading lower after the company's Phase 2/3 GAIN trial did not meet its co-primary endpoints. Cortexyme says they will present the...

Via Benzinga

Here's Why Cortexyme Is Imploding on Wednesday ↗

October 27, 2021

An Alzheimer's disease trial failure was much worse than the company's relatively upbeat look forward suggests.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 27, 2021

Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock...

Via Benzinga

Mid-Day Market Update: Dow Falls Over 100 Points; Silicon Laboratories Shares Spike Higher ↗

October 27, 2021

Midway through trading Wednesday, the Dow traded down 0.30% to 35,648.39 while the NASDAQ rose 0.32% to 15,283.97. The S&P also fell, dropping 0.03% to 4,573.51. The U.S. has...

Via Benzinga

Topics Stocks

Mid-Morning Market Update: Markets Rise; Coca-Cola Tops Q3 Views ↗

October 27, 2021

Following the market opening Wednesday, the Dow traded up 0.16% to 35,814.95 while the NASDAQ rose 0.24% to 15,271.98. The S&P also rose, gaining 0.12% to 4,580.19. The U.S....

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021 ↗

October 27, 2021

Upgrades According to Credit Suisse, the prior rating for Mercer International Inc (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 27, 2021

Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

October 27, 2021

Raymond James raised Alphabet Inc. (NASDAQ:GOOGL

Via Benzinga

28 Stocks Moving in Wednesday's Pre-Market Session ↗

October 27, 2021

Gainers China XD Plastics Company Limited (NASDAQ: CXDC) rose 139% to $1.40 in pre-market trading after jumping around 30% on Tuesday. Guardion Health Sciences, Inc. (NASDAQ:...

Via Benzinga

Why Cortexyme Shares Are Plunging 70% After Hours ↗

October 26, 2021

Shares of a clinical-stage biopharmaceutical company are falling in after-hours trading Tuesday after the company shared an update. What Happened: Cortexyme Inc (NASDAQ: CRTX)...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.